Use of Lamotrigine or Levetiracetam During Pregnancy: No Adverse Effects on Infant Development
Appeared in the 2023 Fall issue of CNS Connections. “Neurodevelopment of babies born to mothers with epilepsy: A prospective observational cohort study.” Bromley RL et al. Epilepsia 2023; 64: 2454-2471.
Read More
Perinatal Ischemic Stroke Can Lead to Autism
Appeared in the 2023 Fall issue of CNS Connections. “Autism spectrum disorder in children with perinatal ischemic stroke varies by stroke type.” Wu CM, et al. Journal of Child Neurology…
Read More
Evidence That Botulium Toxin Works for Pediatric Migraine
Appeared in the 2023 Fall issue of CNS Connections. “Botulimun toxin for pediatric migraine: A retrospective multisite cohort study.” Horvat DE et al. Pediatric Neurology 2023; 147: 68-71.
Read More
An Early Life Epilepsy Research Agenda: Comparative effectiveness, trials, and data science.
Organizer CNS Research Committee Daniel Calame, MD, PhDBaylor College of Medicine Description Early life epilepsy affects 1 in 400 children and is often associated with neurodevelopmental disabilities. This webinar will…
Read More
Treat the Child, Not the EEG? The Impact of Spikes on Brain Connectivity in Children with Self-Limited Epilepsy with Centrotemporal Spikes
Organizer CNS Research Committee Daniel Calame, MD, PhDBaylor College of Medicine Description Children with Self-Limited Epilepsy with Centrotemporal Spikes have seizures and spikes thatcome from the sensorimotor cortices and yet…
Read More
Fetal Exposure to Anticonvulsants and Later Risk of Psychiatric Disease
Appeared in the 2023 Summer issue of CNS Connections. “Prenatal exposure to antiseizure medication and incidence of childhood- and adolescence-onset psychiatric disorders.” Drier JW et al. JAMA Neurology 2023; 80:568-577.
Read More